Patents Examined by Aaron J Kosar
  • Methods for botanical and/or algae extraction
    Patent number: 11234918
    Abstract: The present disclosure relates to methods for extraction of biomass. Biomass of most interest is that which contains biologically active, extracts suitable for the skin care market. The biomass of interest includes botanicals (plant extracts and bioferments thereof), algae (red, brown, green and red, including bioferments thereof), fungi and even animal extracts (insect, crustacean) origin. Further the use of said extracts in cosmetic preparations prepared by the disclosed method is envisioned.
    Type: Grant
    Filed: June 6, 2013
    Date of Patent: February 1, 2022
    Assignee: BASF CORPORATION
    Inventors: Clifford A. Milow, Laurent Bailly, Christopher Judd, Nicole Jeannine Richter
  • Nutraceuticals for suppressing indolamine 2,3 deoxygenase
    Patent number: 11229674
    Abstract: Disclosed are compositions of matter, treatments and protocols useful for reduction of expression and/or activity of indolamine 2,3 deoxygenase (IDO). In some embodiments the invention teaches the administration of a therapeutic combination of ingredients comprising of pterostilbene, Nigella sativa, sulforaphane, and epigallocatechin-3-gallate (EGCG) to a mammal at possessing an increased expression and/or activity of said IDO in which reduction of number and/or activity is desired. In another embodiment, the invention teaches administration of said therapeutic combination to a mammal infected with viral and/or bacterial infections and/or neoplasia. In some embodiments dosage of said therapeutic combination is based on inflammatory and/or immunological parameters observed in patients.
    Type: Grant
    Filed: October 23, 2020
    Date of Patent: January 25, 2022
    Assignee: Therapeutic Solutions International, Inc.
    Inventors: Thomas E. Ichim, Timothy G. Dixon, James Veltmeyer
  • Topical mosquito control product
    Patent number: 11219222
    Abstract: A topical mosquito control product includes active and inert ingredients. The active ingredients include natural materials and may include soybean oil, cinnamon oil, clove oil, thyme and geraniol. The inert ingredients include natural materials and may include bee's wax, sunflower oil, triethyl citrate, water, vanillin, steric acid, xanthan gum and lecithin.
    Type: Grant
    Filed: August 21, 2019
    Date of Patent: January 11, 2022
    Assignee: Penta 5 USA, LLC
    Inventors: R. Charles Murray, John Harlin
  • Ulcerative colitis medication
    Patent number: 11219661
    Abstract: An illustrated side view of an exemplary medication for treating ulcerative colitis is presented. The medication is useful for reducing the risk and debilitation associated with having ulcerative colitis, as well as improving overall health. The medication further is useful for removing life threatening complications such as, but not limited to, perforated colon, liver disease, inflammation of skin, joints and eyes, decreasing the risk of colon cancer while eliminating the need for surgery for relief of the ulcerative colitis. The medication is also inexpensive and all natural.
    Type: Grant
    Filed: January 20, 2020
    Date of Patent: January 11, 2022
    Inventor: Paul Campbell
  • Method for reusing leaves from arborescent woody plants, for the phytopharmaceutical industry
    Patent number: 11213033
    Abstract: The invention relates to a method for reusing deciduous leaves of arborescent woody plants, which allows obtaining an extract used for a phytosanitary application, in particular the elicitation of a plant, preventive or curative treatment of a plant against a pathogenic agent, or improvement of the performance of a phytosanitary product.
    Type: Grant
    Filed: March 6, 2015
    Date of Patent: January 4, 2022
    Inventors: Pascale Goupil, Claire Richard, Alexandra Ter Halle
  • Edible product comprising reconstituted plant material
    Patent number: 11207268
    Abstract: The present invention relates to an edible product, which comprises a fibrous plant product and a plant extract applied thereto. Further, the invention relates to a corresponding method for producing said edible product and its use in at least one of food, food supplement, medicinal, cosmetic, well-being, nutraceutical or phytotherapeutical applications. The plants used may be all plants comprising one or more substances of interest for an edible product.
    Type: Grant
    Filed: August 27, 2019
    Date of Patent: December 28, 2021
    Assignee: Schweitzer-Mauduit International, Inc.
    Inventors: Philippe Ragot, Esther Pons, Bernard Mompon, Cedric Rousseau
  • Composition for preventing or alleviating hangover, containing extract
    Patent number: 11207367
    Abstract: Provided are a pharmaceutical composition for preventing an alcoholic hangover or alleviating a hangover, comprising a Longan arillus extract as an active ingredient, and a food composition for alleviating a hangover, comprising a Longan arillus extract.
    Type: Grant
    Filed: December 26, 2017
    Date of Patent: December 28, 2021
    Assignee: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Hyun Ok Yang, Na Young Bae, Huan Li, Joon Ki Kim
  • Pharmaceutical composition for prevention or treatment of Alzheimer's disease, comprising mountain-cultivated ginseng extract
    Patent number: 11207363
    Abstract: The present invention provides a pharmaceutical composition for preventing or treating Alzheimer's disease and a food composition for relieving symptoms of Alzheimer's disease, which comprise a mountain-cultivated ginseng extract. The composition comprising the mountain-cultivated ginseng extract of the present invention is beneficially used as a pharmaceutical composition for preventing or treating Alzheimer's disease in the medical field for the treatment of Alzheimer's disease or as a food composition for relieving the symptoms of Alzheimer's disease.
    Type: Grant
    Filed: April 26, 2018
    Date of Patent: December 28, 2021
    Assignees: KANGWON NATIONAL UNIVERSITY INDUSTRY COOPERATION FOUNDATION
    Inventors: Sang Il Lee, Hyoung Chun Kim, Sung Kwon Ko, Eun Joo Shin
  • Pharmaceutical compositions for preventions and managements of dementia, infectious diseases, cancers, periodontitis, dental caries, diabetes, obesity, osteoporosis and chronic pain and methods thereof
    Patent number: 11197904
    Abstract: The present invention relates to the area of pharmaceutical compositions. More particularly, the present invention relates to a series of pharmaceutical compositions (PTM) containing phyto-polyphenols (P), clinical drugs with selective targets (T) and a metal ions (M) and the methods thereof for use in prevention and therapy of infectious diseases, neurodegenerative diseases, dementia, diabetes, obesity, metabolic syndromes, osteoporosis, cancers and/or chronic pain.
    Type: Grant
    Filed: January 20, 2019
    Date of Patent: December 14, 2021
    Assignees: Chung Shan Medical University
    Inventor: Shoei-Yn Lin-Shiau
  • Egg protein formulations and methods of manufacture thereof
    Patent number: 11197896
    Abstract: The present technology relates generally to formulations comprising egg white protein, methods of manufacturing egg protein formulations and uses for egg protein formulations. In particular, several embodiments are directed to egg protein formulations for oral administration in immunotherapy of subjects affected by egg allergies.
    Type: Grant
    Filed: August 25, 2015
    Date of Patent: December 14, 2021
    Assignee: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
    Inventor: Howard V. Raff
  • Method for preparing granules or pills containing extracts in high concentration
    Patent number: 11191799
    Abstract: The present invention relates to a method for preparing a granule or a pill containing a plant, medicinal herb or traditional oriental medicine decoction extract, having the steps of: (a) injecting a powdered plant, medicinal herb or traditional oriental medicine decoction extract into a fluidized-bed device and spraying purified water or a solution of the same type of extract as the extract powder at the extract powder while fluidizing the same, thereby generating microgranules of the extract powder; and (b) injecting the microgranules generated at step (a) as seeds into the fluidized-bed device and spraying a solution of the extract while fluidizing the same, thereby growing the microgranules to a predetermined size of granule or pill. According to the present invention, it is possible to prepare a granule or a pill containing an extract in a high concentration.
    Type: Grant
    Filed: August 1, 2018
    Date of Patent: December 7, 2021
    Assignee: ARIBIO CO., LTD.
    Inventors: Chil Surk Yoon, Jai Jun Choung, Soo Hyun Sung
  • Extracts of , methods for preparation and use thereof
    Patent number: 11191798
    Abstract: Disclosed herein are extracts of Andrographis paniculata having highly concentrated active ingredients, preparation methods and medical use for treating autoimmunity and inflammatory disease.
    Type: Grant
    Filed: November 1, 2017
    Date of Patent: December 7, 2021
    Assignee: NUTRITION SCIENCE PARTNERS LIMITED
    Inventors: Wei-Guo Su, Xiong Li, Weihan Zhang, Bo Liu, Huaqing Cai, Zhilong Weng, Hongqiang Wang, Zhiyong Yu, Lei Jiang
  • Uses of extract
    Patent number: 11173107
    Abstract: A method for at least one of whitening skin, improving skin condition, protecting skin, and treating skin disease is provided, wherein the method comprises administering to a subject in need an effective amount of a Pyrenaria buisanensis extract. A method for at least one of preventing cardiovascular disease, treating cardiovascular disease, preventing diabetes, treating diabetes, preventing neurodegenerative disease, and treating neurodegenerative disease is also provided, wherein the method comprises administering to a subject in need an effective amount of a Pyrenaria buisanensis extract.
    Type: Grant
    Filed: October 16, 2018
    Date of Patent: November 16, 2021
    Assignee: TCI CO., LTD.
    Inventors: Yung-Hsiang Lin, Yu-Ting Lin
  • Pharmaceutical composition for the treatment of malignant neoplasms including sarcoma, cancers of liver, lung, bladder, blood and cervical, treatment of infectious diseases and type 2 diabetes
    Patent number: 11167002
    Abstract: The present invention relates to a pharmaceutical composition. The pharmaceutical composition is the organic phase of raw garlic (Allium sativum, all species) or water extraction to provide novel cancer treatments of multiple malignant neoplasms, infectious diseases and Type 2 diabetes. The effective formulation of OPRGE is either liquid or dry powder of OPRGE; the effective routes of administration is intravenous (IV) for infectious diseases and diabetes; the effective routes of administration is intravenous (IV) or intraperitoneal (IP) or intratumoral infusions for malignant neoplasms. The patent application consistent of OPRGE extraction methods, mode of administration of OPRGE and clinical indications.
    Type: Grant
    Filed: September 20, 2019
    Date of Patent: November 9, 2021
    Inventor: David Xiage Gan
  • Method of treating coronavirus infections
    Patent number: 11166999
    Abstract: The present application relates to a compositions and methods comprising or expressing a MOMO30 protein derived from Momordica balsamina. The MOMO30 protein is about 30 kDa in size, binds coronavirus S protein, is stable after being autoclaved at 120° C. for 30 min, resists proteolytic cleavage by trypsin, exhibits mannose-sensitive binding to coronavirus spike (S) protein, exhibits hemagglutinin and chitinase activity, is capable of activating and stimulating T cell proliferation, is capable of preventing infection by a coronavirus or alleviating symptoms in coronavirus infected patients and comprises the amino acid sequence of SEQ ID NO: 1. The MOMO30 protein and/or a nucleic acid encoding the same may be used in methods for preventing or treating viral infections by coronaviruses and others.
    Type: Grant
    Filed: August 18, 2020
    Date of Patent: November 9, 2021
    Assignee: MOREHOUSE SCHOOL OF MEDICINE
    Inventors: Michael Powell, Erick Vidjin′ Agnih Gbodossou
  • Uses and development of neurodefend for treating neurodegenerative diseases
    Patent number: 11167000
    Abstract: A herbal composition with significant potent therapeutic effects for treating neurodegenerative diseases by targeting both amyloid-? (A?) and tau-associated neurofibrillary tangles (NFTs) is provided.
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: November 9, 2021
    Assignee: Hong Kong Baptist University
    Inventors: Min Li, Ashok Iyaswamy, Siva Sundara Kumar Durairajan, Senthilkumar Krishnamoorthi, Huan Zhang, Sravan G. S. Sreenivasamurthy
  • Methods and materials for treating diabetes or liver steatosis
    Patent number: 11160825
    Abstract: This document provides methods and materials for treating diabetes and/or liver steatosis. For example, methods for using compositions containing a potato polysaccharide preparation to reduce one or more symptoms of diabetes or liver steatosis are provided. In some cases, a composition containing a potato polysaccharide preparation provided herein can be used to treat fatty liver disease.
    Type: Grant
    Filed: August 29, 2014
    Date of Patent: November 2, 2021
    Assignee: Research Foundation of the State University of New York
    Inventors: George B. Stefano, Richard Kream, Kirk J Mantione
  • Compositions and methods of use
    Patent number: 11154578
    Abstract: The present invention provides a composition comprising honey, a preservative and an aqueous carrier, wherein the honey is present in an amount in the range of from 2 to 50% w/w. Uses of the compositions of the invention for the management, treatment or prevention of a respiratory, ophthalmic, ear or vaginal condition in a subject, and for wound management are also described.
    Type: Grant
    Filed: July 20, 2015
    Date of Patent: October 26, 2021
    Assignee: MELGARE MEDICAL PTY LTD
    Inventor: Anthony Peter Moloney
  • Use of Undaria extract to reduce signs of skin aging
    Patent number: 11154491
    Abstract: Compositions for reducing skin aging are disclosed herein. The compositions can be topically applied to a skin region to reduce or prevent skin wrinkles, fine lines, thinning skin, sagging skin, skin dryness, and skin itchiness.
    Type: Grant
    Filed: April 30, 2014
    Date of Patent: October 26, 2021
    Assignee: Kimberly-Clark Worldwide, Inc.
    Inventors: Scott W. Wenzel, David J. Tyrrell, Alencia Vanay Grice, Stephanie VandeVen Teat, Jeffery Richard Seidling
  • Translucent, dehydrated placental tissue and methods of producing and using the same
    Patent number: 11154641
    Abstract: Compositions comprising translucent, dehydrated placental tissue and methods of preparing and using those tissues are provided. Repeated dehydration techniques may produce translucent, dehydrated placental tissues, including translucent, dehydrated placental membrane and umbilical cord, with improved visualization and/or handling characteristics. The present invention also includes methods of healing a wound of the skin, eye, nerve, tendon, muscle, dental region, or dura, including burns, comprising applying the translucent, dehydrated placental tissues of the invention to the wound.
    Type: Grant
    Filed: December 19, 2018
    Date of Patent: October 26, 2021
    Assignee: STIMLABS LLC
    Inventors: John Daniel, Sarah Griffiths, Annelise Mowry Roy